Steven Bariahtaris Appointed Interim Chief Financial Officer RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced Steven Bariahtaris has been appointed interim Chief Financial […]
Financial
Sanifit Appoints Adam Levy as Chief Financial Officer
Sanifit Appoints Adam Levy as Chief Financial Officer Palma, Spain and San Diego, USA, 20 August 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced the appointment of Adam Levy as Chief Financial Officer, with immediate effect. Mr. Levy was most recently with Brickell […]
Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million
Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million The Extraordinary General Meeting of Acarix AB (“Acarix” or the “Company”) resolved on 11 August 2020, subsequent to the board of directors proposal on 15 July 2020, to carry out a new share issue of a maximum […]
Ontrak Announces Public Offering of Non-Convertible Perpetual Preferred Stock
Company to use non-dilutive capital for working capital, M&A, investment in technology SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that it has commenced an underwritten public offering of shares of its Series A Cumulative Perpetual […]
CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering
EDEN PRAIRIE, Minn., Aug. 19, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $12.5 million prior to deducting underwriting […]
iRhythm Technologies Announces Proposed Public Offering of Common Stock
SAN FRANCISCO, Aug. 18, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that it has commenced an underwritten public offering of 1,000,000 shares of its common stock. All of the shares in the […]
American Society for Preventive Cardiology (ASPC) Announces Newly Elected President Peter P. Toth, MD, PhD, FASPC
JACKSONVILLE, Fla., Aug. 17, 2020 /PRNewswire/ — During the ASPC annual business meeting during the recent 2020 ASPC Virtual Summit on CVD Prevention, Peter P. Toth, MD, PhD, FASPC was officially elected as the President of the American Society for Preventive Cardiology (ASPC). ASPC is a national multidisciplinary membership organization dedicated to the prevention […]
Semler Scientific Expands Board of Directors with Appointment of Industry Veteran Daniel Messina
SAN JOSE, Calif., Aug. 17, 2020 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Daniel Messina, an experienced and well regarded health services executive and entrepreneur, to its Board of Directors, effective August 13, 2020. […]
Neovasc Announces Partial Prepayment of Convertible Debenture
VANCOUVER and MINNEAPOLIS, Aug. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase Agreement dated […]
Blackstone and Alnylam Close $150 Million R&D Financing to Advance RNAi Therapeutics for Cardiovascular Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Blackstone (NYSE: BX) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the closing of the R&D funding component of the companies’ previously announced $2 billion strategic financing collaboration to accelerate the advancement of RNAi therapeutics. Under the terms of the agreement, Alnylam will receive up to […]



